Article
Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology
26 Aug 2011
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) remains a devastating disease despite tremendous scientific efforts. Numerous trials have failed to improve the outcome on this deadliest of all major cancers. Potential causes include a still insufficient understanding of key features of this cancer and imperfect preclinical models for identification of active agents and mechanisms of therapeutic responses and resistance....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
